NO920681L - Kinolinholdige ketosyrer som leukotrien-antagonister - Google Patents
Kinolinholdige ketosyrer som leukotrien-antagonisterInfo
- Publication number
- NO920681L NO920681L NO92920681A NO920681A NO920681L NO 920681 L NO920681 L NO 920681L NO 92920681 A NO92920681 A NO 92920681A NO 920681 A NO920681 A NO 920681A NO 920681 L NO920681 L NO 920681L
- Authority
- NO
- Norway
- Prior art keywords
- ketosy
- quinol
- acids
- contained
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65893191A | 1991-02-21 | 1991-02-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO920681D0 NO920681D0 (no) | 1992-02-20 |
| NO920681L true NO920681L (no) | 1992-08-24 |
Family
ID=24643302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92920681A NO920681L (no) | 1991-02-21 | 1992-02-20 | Kinolinholdige ketosyrer som leukotrien-antagonister |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0500360B1 (cs) |
| JP (1) | JPH0788361B2 (cs) |
| KR (1) | KR920016423A (cs) |
| CN (1) | CN1065062A (cs) |
| AT (1) | ATE154801T1 (cs) |
| AU (1) | AU648385B2 (cs) |
| CA (1) | CA2061675C (cs) |
| CS (1) | CS47192A3 (cs) |
| DE (1) | DE69220517T2 (cs) |
| ES (1) | ES2104821T3 (cs) |
| FI (1) | FI920734L (cs) |
| HU (1) | HU9200552D0 (cs) |
| IE (1) | IE920499A1 (cs) |
| IL (1) | IL100985A0 (cs) |
| MX (1) | MX9200714A (cs) |
| NO (1) | NO920681L (cs) |
| ZA (1) | ZA921232B (cs) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| GB9216768D0 (en) * | 1992-08-07 | 1992-09-23 | Leo Pharm Prod Ltd | Chemical compounds |
| KR19990008148A (ko) * | 1995-04-28 | 1999-01-25 | 다께다 구니오 | 관절염 치료 조성물 |
| AU3868497A (en) * | 1996-08-26 | 1998-03-19 | Yamanouchi Pharmaceutical Co., Ltd. | Benzenesulfone compounds and salts thereof |
| DE69900207T2 (de) * | 1998-07-14 | 2001-11-22 | Alcon Laboratories, Inc. | Verwendung von 11-(3-dimethylaminopropyliden)-6,11-dihydrodibenz[b,e]oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation |
| US7547787B2 (en) | 2004-04-21 | 2009-06-16 | Teva Pharmaceutical Industries Ltd. | Processes for preparing montelukast sodium |
| ITMI20050247A1 (it) * | 2005-02-18 | 2006-08-19 | Chemi Spa | Processo per la preparazione di montelukast |
| WO2006131782A1 (en) * | 2005-06-07 | 2006-12-14 | Glade Organics Private Limited | Process for the manufacture of methyl-2-(3-(2-(7-chloro-2-quinolinyl-ethenyl)-phenyl)-3-oxopropyl) benzoate |
| EP1904448B1 (en) | 2005-07-05 | 2011-02-02 | Teva Pharmaceutical Industries, Ltd. | Purification of montelukast |
| CN101365683A (zh) * | 2005-11-18 | 2009-02-11 | 斯索恩有限公司 | 制备孟鲁司特及其中间体的方法 |
| AR057909A1 (es) * | 2005-11-18 | 2007-12-26 | Synthon Bv | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. |
| KR20090080038A (ko) * | 2006-09-15 | 2009-07-23 | 씨아이피엘에이 엘티디. | 몬테루카스트의 제조방법 및 그의 중간체 |
| ES2320077B1 (es) | 2007-07-31 | 2010-02-26 | Moehs Iberica, S.L. | Proceso de preparacion de un antagonista de leucotrienos y de un intermedio del mismo. |
| CN101851196B (zh) * | 2010-05-28 | 2011-07-27 | 中国科学院昆明植物研究所 | 2-(1h)喹啉酮衍生物,其药物组合物及其制备方法和用途 |
| KR20140108627A (ko) * | 2011-07-26 | 2014-09-12 | 썬 파마 어드밴스트 리서치 컴패니 리미티드 | 퀴놀린-, 퀸옥살린 또는 벤조티아졸계 시스테이닐 류코트리엔 길항물질 (ltc4) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE59889B1 (en) * | 1986-02-14 | 1994-04-20 | Merck Frosst Canada Inc | 2-substituted quinoline dioic acids |
| EP0318093A3 (en) * | 1987-11-25 | 1990-12-05 | Merck Frosst Canada Inc. | Diarylquinoline diacids and their use as medicaments |
| EP0349062A1 (en) * | 1988-06-27 | 1990-01-03 | Merck Frosst Canada Inc. | Quinoline ether alkanoic acid |
| NZ233752A (en) * | 1989-05-24 | 1993-05-26 | Merck Frosst Canada Inc | Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof |
-
1992
- 1992-02-17 IE IE049992A patent/IE920499A1/en not_active Application Discontinuation
- 1992-02-18 IL IL100985A patent/IL100985A0/xx unknown
- 1992-02-18 CS CS92471A patent/CS47192A3/cs unknown
- 1992-02-20 AT AT92301393T patent/ATE154801T1/de not_active IP Right Cessation
- 1992-02-20 HU HU9200552A patent/HU9200552D0/hu unknown
- 1992-02-20 FI FI920734A patent/FI920734L/fi not_active Application Discontinuation
- 1992-02-20 CN CN92102076A patent/CN1065062A/zh active Pending
- 1992-02-20 NO NO92920681A patent/NO920681L/no unknown
- 1992-02-20 MX MX9200714A patent/MX9200714A/es unknown
- 1992-02-20 AU AU11119/92A patent/AU648385B2/en not_active Ceased
- 1992-02-20 DE DE69220517T patent/DE69220517T2/de not_active Expired - Fee Related
- 1992-02-20 ES ES92301393T patent/ES2104821T3/es not_active Expired - Lifetime
- 1992-02-20 EP EP92301393A patent/EP0500360B1/en not_active Expired - Lifetime
- 1992-02-20 KR KR1019920002536A patent/KR920016423A/ko not_active Withdrawn
- 1992-02-20 ZA ZA921232A patent/ZA921232B/xx unknown
- 1992-02-21 JP JP4034632A patent/JPH0788361B2/ja not_active Expired - Lifetime
- 1992-02-21 CA CA002061675A patent/CA2061675C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0525135A (ja) | 1993-02-02 |
| EP0500360B1 (en) | 1997-06-25 |
| FI920734A7 (fi) | 1992-08-22 |
| ZA921232B (en) | 1992-10-28 |
| CA2061675C (en) | 2002-12-17 |
| DE69220517D1 (de) | 1997-07-31 |
| KR920016423A (ko) | 1992-09-24 |
| JPH0788361B2 (ja) | 1995-09-27 |
| DE69220517T2 (de) | 1997-12-18 |
| ATE154801T1 (de) | 1997-07-15 |
| MX9200714A (es) | 1992-10-01 |
| HU9200552D0 (en) | 1992-05-28 |
| CS47192A3 (en) | 1992-10-14 |
| NO920681D0 (no) | 1992-02-20 |
| CA2061675A1 (en) | 1992-08-22 |
| CN1065062A (zh) | 1992-10-07 |
| FI920734A0 (fi) | 1992-02-20 |
| IE920499A1 (en) | 1992-08-26 |
| AU1111992A (en) | 1992-08-27 |
| ES2104821T3 (es) | 1997-10-16 |
| IL100985A0 (en) | 1992-11-15 |
| AU648385B2 (en) | 1994-04-21 |
| FI920734L (fi) | 1992-08-22 |
| EP0500360A1 (en) | 1992-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE165088T1 (de) | Ungesättigte hydroxyalkylchinolinsäuren als leukotrien-antagonisten | |
| NO920681L (no) | Kinolinholdige ketosyrer som leukotrien-antagonister | |
| AU3686393A (en) | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists | |
| NO962717L (no) | Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister | |
| NO952495D0 (no) | Diaryl-5,6-kondenserte heterosykliske syrer som leukotrienantagonister | |
| NO914003L (no) | Fremgangsmaate for fremstilling av hydroxyalkylkinolinethersyrer som leukotrienantagonister | |
| CA2163244A1 (en) | Quinoline derivatives as leukotriene antagonists | |
| ATE317224T1 (de) | Chinolin-leukotrien-antagonisten | |
| WO1995004741A1 (en) | Aza-5,5-fused heterocyclic acids as leukotriene antagonists | |
| MY107767A (en) | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists | |
| CA2223414A1 (en) | Heteroaryl diol acids as leukotriene antagonists |